The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016

Published:2017-02-15 Issue:39 Volume:38 Page:2930-2935
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Mathur Anthony¹,Fernández-Avilés Francisco²,Dimmeler Stefanie³,Hauskeller Christine⁴,Janssens Stefan⁵,Menasche Philippe⁶,Wojakowski Wojtek⁷,Martin John F⁸,Zeiher Andreas³,

Affiliation:

1. Queen Mary University of London

2. Hospital General Universitario Gregorio Marañón, Madrid

3. Johann-Wolfgang-Goethe University, Frankfurt

4. Egenis, Exeter Centre for the Study of Life Sciences, University of Exeter

5. University Hospitals Leuven

6. Assistance Publique Hopitaux de Paris University Paris Descartes

7. Medical University of Silesia, Katowice, Poland

8. University College London

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/39/2930/24120731/ehw640.pdf

Reference27 articles.

1. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart;Bartunek;Eur Heart J,2006

2. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction;Schachinger;N Engl J Med,2006

3. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial;Heldman;JAMA,2014

4. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial);Mathiasen;Eur Heart J,2015

5. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial;Bolli;Lancet,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regenerative Medicine and Nanotechnology approaches against Cardiovascular Diseases: Recent Advances and Future Prospective;Current Stem Cell Research & Therapy;2024-02-09

2. Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine;Journal of Controlled Release;2024-01

3. A Combination of Distinct Vascular Stem/Progenitor Cells for Neovascularization and Ischemic Rescue;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-07

4. The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review;Tissue Engineering Part B: Reviews;2023-04-01

5. Pharmacological Treatment of Ischemic Heart Disease;Ischemic Heart Disease;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3